INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/21/2024
Back to search
Official data from USPTO
KINVITRAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
01/21/2024
Trademark type
Word
Nice classes
5
Filing date
02/03/2016
Registration date
09/13/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2023
Last transaction
03/24/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
PAQUIN, SAMUEL ROBERT
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations and stem cells for pharmaceutical and medical purposes
Publications
History of USPTO decisions and trademark events.
33 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/28/2023
INPC
INVALIDATION PROCESSED
12/28/2023
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/24/2023
C71T
CANCELLED SECTION 71
03/24/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/13/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/09/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/24/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/02/2017
FIMP
FINAL DISPOSITION PROCESSED
02/02/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/13/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2016
PUBO
PUBLISHED FOR OPPOSITION
06/28/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/08/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/08/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2016
RFNP
REFUSAL PROCESSED BY IB
05/27/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/17/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/17/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/09/2016
RFRR
REFUSAL PROCESSED BY MPU
05/09/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/07/2016
CNRT
NON-FINAL ACTION WRITTEN
05/06/2016
DOCK
ASSIGNED TO EXAMINER
05/04/2016
MAFR
APPLICATION FILING RECEIPT MAILED
04/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/28/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/25/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/24/2016
Continuous trademark protection
Get notified about every new filing that threatens KINVITRAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.